Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time
- PMID: 20644184
- PMCID: PMC2906524
- DOI: 10.1370/afm.1112
Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time
Abstract
Purpose: Colorectal cancer (CRC) screening remains underutilized. The objective of this study was to examine the impact of primary care and economic barriers to health care on CRC testing relative to the 2001 Medicare expansion of screening coverage.
Methods: Medicare Current Beneficiary Survey data were use to study community-dwelling enrollees aged 65 to 80 years, free of renal disease and CRC, and who participated in the survey in 2000 (n = 8,330), 2003 (n = 7,889), or 2005 (n = 7,614). Three outcomes were examined: colonoscopy/sigmoidoscopy within 5 years (recent endoscopy), endoscopy more than 5 years previously, and fecal occult blood test (FOBT) within 2 years.
Results: Endoscopy use increased and FOBT use decreased during the 6-year period, with no significant independent differences between those receiving care from primary care physicians and those receiving care from other physicians. Beneficiaries without a usual place of health care were the least likely to undergo CRC testing, and that gap widened with time: adjusted odds ratio (AOR) = 0.27 (95% confidence interval [CI], 0.19-0.39) for FOBT, and AOR = 0.35 (95% CI, 0.27-0.46) for endoscopy in 2000 compared with AOR = 0.18 (95% CI, 0.11-0.30) for FOBT and AOR = 0.22 (95% CI, 0.17-0.30) for endoscopy in 2005. Disparities in use of recent endoscopy by type of health insurance coverage in both 2000 and 2005 were greater for enrollees with a high school education or higher than they were for less-educated enrollees. There were no statistically significant differences by delayed care due to cost after adjustment for health insurance.
Conclusion: Despite expanding coverage for screening, complex CRC screening disparities persisted based on differences in the usual place and cost of health care, type of health insurance coverage, and level of education.
Figures
Similar articles
-
Trends in colorectal cancer testing among Medicare subpopulations.Am J Prev Med. 2008 Sep;35(3):194-202. doi: 10.1016/j.amepre.2008.05.029. Epub 2008 Jul 10. Am J Prev Med. 2008. PMID: 18619761
-
Self-reported colorectal cancer screening of Medicare beneficiaries in family medicine vs. internal medicine practices in the United States: a cross-sectional study.BMC Gastroenterol. 2012 Mar 21;12:23. doi: 10.1186/1471-230X-12-23. BMC Gastroenterol. 2012. PMID: 22436107 Free PMC article.
-
Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005.Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2170-5. doi: 10.1158/1055-9965.EPI-09-0104. Epub 2009 Jul 21. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19622721 Free PMC article.
-
Disparities in endoscopy use for colorectal cancer screening in the United States.Dig Dis Sci. 2014 Mar;59(3):530-7. doi: 10.1007/s10620-013-2937-x. Epub 2013 Nov 19. Dig Dis Sci. 2014. PMID: 24248417 Review.
-
Colorectal cancer screening among Korean Americans: a systematic review.J Community Health. 2014 Apr;39(2):193-200. doi: 10.1007/s10900-013-9758-x. J Community Health. 2014. PMID: 23982772 Review.
Cited by
-
Utilization of colorectal cancer screening tests: a systematic review and time trend analysis of nationally representative data.EClinicalMedicine. 2024 Aug 21;75:102783. doi: 10.1016/j.eclinm.2024.102783. eCollection 2024 Sep. EClinicalMedicine. 2024. PMID: 39263675 Free PMC article. Review.
-
Improving Colorectal Cancer Screening in a Regional Safety-Net Health System over a 10-Year Period: Lessons for Population Health.J Gen Intern Med. 2024 May;39(6):978-984. doi: 10.1007/s11606-023-08477-w. Epub 2023 Nov 6. J Gen Intern Med. 2024. PMID: 37932541
-
Racial Differences in Strength of Associations Between Colorectal Cancer Screening, Area Deprivation, Demographics, and Clinical Characteristics.Ochsner J. 2023 Fall;23(3):194-205. doi: 10.31486/toj.23.0012. Ochsner J. 2023. PMID: 37711477 Free PMC article.
-
Tools to Measure the Impact of Structural Racism and Discrimination on Gastrointestinal and Hepatology Disease Outcomes: A Scoping Review.Clin Gastroenterol Hepatol. 2023 Oct;21(11):2759-2788.e6. doi: 10.1016/j.cgh.2022.12.002. Epub 2022 Dec 20. Clin Gastroenterol Hepatol. 2023. PMID: 36549469 Free PMC article. Review.
-
Application of artificial intelligence to the diagnosis and therapy of colorectal cancer.Am J Cancer Res. 2020 Nov 1;10(11):3575-3598. eCollection 2020. Am J Cancer Res. 2020. PMID: 33294256 Free PMC article. Review.
References
-
- Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328(19):1365–1371. - PubMed
-
- Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326(10):653–657. - PubMed
-
- Winawer SJ, Zauber AG, Ho MN, et al; The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329(27):1977–1981. - PubMed
-
- Centers for Disease Control and Prevention (CDC). Use of colorectal cancer tests—United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep. 2008;57(10):253–258. - PubMed
-
- Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008;17(7): 1623–1630. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous